RESI conference and Digital medicine connect at Biopharm America

Christine Charette, SVP Strategic Finance, OBIO offers her perspective on the RESI conference and BioPharm America.

For a PDF of the full article, click here

Previous
Previous

RESI Conference and Digital Medicine Connect at Biopharm America: Part 2

Next
Next

Beyond Novelty: Adopting & Diffusing Innovation in the Supply Chain